Owners, management and financials
CVR: 26186676
Previous names: VISIOPHARM ApS
DKK 130,617,000
Revenue
Net result: DKK -17,223,000
Neptune Denmark Holdco ApS (100%)
CVR · view owners
Johan Doré Hansen, Michael Grunkin
Board: Evis Hursever (chair) and 2 members
CVR · view management
Active
Founded 9 July 2001
CVR · view overview
48 employees
CVR · 2018
Owner registered: Neptune Denmark Holdco ApS
CVR · 19/05/2026
View the full event history
VISIOPHARM A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2001. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named VISIOPHARM ApS. The management consists of Johan Doré Hansen and Michael Grunkin. The board consists of Evis Hursever (chair), Andrew James Thomson and Per Fredrik Thorell. The company is owned by Neptune Denmark Holdco ApS. The company has 48 employees (2018). In 2025, the company reported revenue of DKK 130,617,000 and a net result of DKK -17,223,000 compared with DKK -17,363,000 the year before. Equity in the 2025 report amounted to DKK -4,949,000.
Source: annual report 2025, Danish Business Authority
The financial health of VISIOPHARM A/S shows significant challenges, with consistent losses over the past five years. Revenue has fluctuated slightly, peaking at 135,974,000 DKK in 2022 but declining to 130,617,000 DKK in 2025, while profit margins remain negative, culminating in a loss of 17,223,000 DKK in 2025. Equity has deteriorated sharply from 59,406,000 DKK in 2021 to -4,949,000 DKK in 2025, indicating a concerning trend of increasing financial instability. The company's position within the computer consulting and facility management industry appears precarious, with ongoing profitability issues and a declining equity base raising concerns about its sustainability and growth potential.
AI-generated summary · Generated 11/03/2026
Selskabets formål er at drive virksomhed med udvikling og salg af produkter og serviceydelser til brug indenfor drug discovery og anden i forbindelse dermed stående virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/10/2024 – 30/09/2025 | 130.6 mio. | -17.2 mio. | 97.9 mio. | -4.9 mio. | 82 | |
| 202401/10/2023 – 30/09/2024 | 118.2 mio. | -17.4 mio. | 118.4 mio. | 9.2 mio. | 88 | |
| 202301/10/2022 – 30/09/2023 | 112.1 mio. | -30.3 mio. | 129 mio. | 25.5 mio. | 96 | |
| 202201/10/2021 – 30/09/2022 | 136 mio. | -20.6 mio. | 107.6 mio. | 33.9 mio. | 105 | |
| 202101/10/2020 – 30/09/2021 | 108.5 mio. | -41.3 mio. | 133.6 mio. | 59.4 mio. | - | |
| 202001/10/2019 – 30/09/2020 | 84.3 mio. | -26.3 mio. | 154.2 mio. | 100.5 mio. | - | |
| 201901/10/2018 – 30/09/2019 | 87.9 mio. | 21.7 mio. | 115.5 mio. | 77.1 mio. | - | |
| 201801/10/2017 – 30/09/2018 | 56.2 mio. | -12 mio. | 127.7 mio. | 99.3 mio. | - | |
| 201701/10/2016 – 30/09/2017 | 27.2 mio. | -206 t. | 36 mio. | 22.7 mio. | 37 | |
| 201601/10/2015 – 30/09/2016 | - | -628 t. | 20.4 mio. | 13.2 mio. | - | |
| 201501/10/2014 – 30/09/2015 | - | 1.3 mio. | 19.8 mio. | 13.8 mio. | - | |
| 201401/10/2013 – 30/09/2014 | - | 1.1 mio. | 12.5 mio. | 6.6 mio. | - | |
| 201301/10/2012 – 30/09/2013 | - | -797 t. | 10.7 mio. | 5.5 mio. | - | |
| 201201/10/2011 – 30/09/2012 | - | -958 t. | 9.2 mio. | 5.5 mio. | - |
Compared to 6.312 companies in Computerkonsulentbistand og forvaltning af computerfaciliteter
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of VISIOPHARM A/S is 26186676.
VISIOPHARM A/S is owned by Neptune Denmark Holdco ApS.
The management of VISIOPHARM A/S consists of Johan Doré Hansen and Michael Grunkin.
The board of VISIOPHARM A/S consists of Evis Hursever, Andrew James Thomson and Per Fredrik Thorell, with Evis Hursever as chair.
In 2025, VISIOPHARM A/S reported revenue of DKK 130,617,000.
VISIOPHARM A/S had 48 employees in 2018 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Contact info changed: new phone: 88202088 (September 15, 2026).
Contact info changed: new phone: 88202088 (May 20, 2026).
Contact info changed: new phone: 88202088 (May 20, 2026).
As of May 19, 2026, Per Fredrik Thorell has joined the board of directors of VISIOPHARM A/S.
As of May 19, 2026, Evis Hursever has joined the board of directors of VISIOPHARM A/S.
As of May 19, 2026, Andrew James Thomson has joined the board of directors of VISIOPHARM A/S.
As of May 19, 2026, Susanne Høiberg has left the board of directors of VISIOPHARM A/S.
As of May 19, 2026, Thomas Weilby Knudsen has left the board of directors of VISIOPHARM A/S.
As of May 19, 2026, Claus Henrik Berner Møller has left the board of directors of VISIOPHARM A/S.
As of May 19, 2026, Martin Bonde has left the board of directors of VISIOPHARM A/S.
As of May 19, 2026, Jeannett Hvidkjær has left the board of directors of VISIOPHARM A/S.
As of May 19, 2026, Patrik Olof Dahlén has left the board of directors of VISIOPHARM A/S.
As of May 19, 2026, Morten Frost Norgreen has left the board of directors of VISIOPHARM A/S.
As of May 19, 2026, Neptune Denmark Holdco ApS is registered as an owner of VISIOPHARM A/S with an ownership share of 100%.
VISIOPHARM A/S has published its annual report for 2025. Revenue came to DKK 130,617,000, and the net result was DKK -17,223,000.
As of June 4, 2025, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of VISIOPHARM A/S.
As of June 4, 2025, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of VISIOPHARM A/S.
VISIOPHARM A/S has published its annual report for 2024. Revenue came to DKK 118,186,000, and the net result was DKK -17,363,000.
VISIOPHARM A/S has published its annual report for 2023. Revenue came to DKK 112,093,000, and the net result was DKK -30,288,000.
VISIOPHARM A/S has published its annual report for 2022. Revenue came to DKK 135,974,000, and the net result was DKK -20,612,000.
VISIOPHARM A/S has published its annual report for 2021. Revenue came to DKK 108,495,000, and the net result was DKK -41,341,000.
As of December 21, 2021, Jeannett Hvidkjær has joined the board of directors of VISIOPHARM A/S.
As of December 21, 2021, Morten Frost Norgreen has joined the board of directors of VISIOPHARM A/S.
As of December 21, 2021, Henrik Stender has left the board of directors of VISIOPHARM A/S.
VISIOPHARM A/S has published its annual report for 2020. Revenue came to DKK 84,262,000, and the net result was DKK -26,308,000.
VISIOPHARM A/S has published its annual report for 2019. Revenue came to DKK 87,920,000, and the net result was DKK 21,686,000.
As of December 23, 2019, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of VISIOPHARM A/S.
As of December 23, 2019, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of VISIOPHARM A/S.
VISIOPHARM A/S has published its annual report for 2018. Revenue came to DKK 56,156,000, and the net result was DKK -11,961,000.
As of July 6, 2018, Claus Henrik Berner Møller has joined the board of directors of VISIOPHARM A/S.
As of June 13, 2018, Martin Bonde has joined the board of directors of VISIOPHARM A/S.
As of June 13, 2018, Michael Grunkin has left the board of directors of VISIOPHARM A/S.
As of June 13, 2018, Johan Doré Hansen has left the board of directors of VISIOPHARM A/S.
As of June 13, 2018, Per Arne Rickard Lindelöf has left the board of directors of VISIOPHARM A/S.
VISIOPHARM A/S has published its annual report for 2017. Revenue came to DKK 27,192,000, and the net result was DKK -206,000.
As of December 22, 2017, Per Arne Rickard Lindelöf has joined the board of directors of VISIOPHARM A/S.
VISIOPHARM A/S has published its annual report for 2016. Gross profit came to DKK 15,846,479, and the net result was DKK -628,489.
VISIOPHARM A/S has published its annual report for 2015. Gross profit came to DKK 11,751,802, and the net result was DKK 1,255,711.
VISIOPHARM A/S has published its annual report for 2014. Gross profit came to DKK 9,282,806, and the net result was DKK 1,064,445.
As of February 27, 2015, Susanne Høiberg has joined the board of directors of VISIOPHARM A/S.
As of February 27, 2015, Patrik Olof Dahlén has joined the board of directors of VISIOPHARM A/S.
As of February 26, 2015, Susanne Høiberg has left the board of directors of VISIOPHARM A/S.
VISIOPHARM A/S has published its annual report for 2013. Gross profit came to DKK 6,364,341, and the net result was DKK -796,604.
VISIOPHARM A/S has published its annual report for 2012. Gross profit came to DKK 7,334,504, and the net result was DKK -958,323.
As of December 28, 2012, Henrik Stender has joined the board of directors of VISIOPHARM A/S.
As of December 28, 2012, Martin Bonde has left the board of directors of VISIOPHARM A/S.
As of May 25, 2012, Niels Tækker Foged has stepped down as director of VISIOPHARM A/S.
As of February 21, 2012, Johan Doré Hansen has joined the board of directors of VISIOPHARM A/S.
As of February 21, 2012, Niels Tækker Foged has left the board of directors of VISIOPHARM A/S.
As of September 24, 2010, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of VISIOPHARM A/S.
As of September 24, 2010, VICH 2938 A/S has stepped down as auditor of VISIOPHARM A/S.
As of September 28, 2007, Niels Tækker Foged has joined the board of directors of VISIOPHARM A/S.
As of September 28, 2007, Steen Bundgaard Lauritzen has left the board of directors of VISIOPHARM A/S.
As of January 17, 2007, Jens Harpøth Zilstorff has left the board of directors of VISIOPHARM A/S.
As of September 28, 2006, Niels Tækker Foged is registered as director of VISIOPHARM A/S.
As of September 28, 2006, Johan Doré Hansen is registered as director of VISIOPHARM A/S.
As of January 31, 2006, Thomas Weilby Knudsen has joined the board of directors of VISIOPHARM A/S.
On January 24, 2005, the company changed its name from VISIOPHARM ApS to VISIOPHARM A/S.
As of October 8, 2002, Martin Bonde has joined the board of directors of VISIOPHARM A/S.
As of July 19, 2002, Michael Grunkin has joined the board of directors of VISIOPHARM A/S.
As of July 19, 2002, Susanne Høiberg has joined the board of directors of VISIOPHARM A/S.
As of July 19, 2002, Anders Weber has left the board of directors of VISIOPHARM A/S.
As of June 3, 2002, Anders Weber has joined the board of directors of VISIOPHARM A/S.
As of June 3, 2002, Michael Grunkin has left the board of directors of VISIOPHARM A/S.
As of July 9, 2001, VICH 2938 A/S has been appointed auditor of VISIOPHARM A/S.
As of July 9, 2001, Michael Grunkin has joined the board of directors of VISIOPHARM A/S.
As of July 9, 2001, Steen Bundgaard Lauritzen has joined the board of directors of VISIOPHARM A/S.
As of July 9, 2001, Jens Harpøth Zilstorff has joined the board of directors of VISIOPHARM A/S.
As of July 9, 2001, Michael Grunkin is registered as director of VISIOPHARM A/S.
VISIOPHARM A/S was founded on July 9, 2001.
Companies in the same industry and area
CVR 26699339
CVR 33364334
CVR 28099223
CVR 44909995
CVR 29529027
